Research News
Hwang to Lead UNC Center for Diabetes and Metabolic Health, Funding by NIDDK RenewedDiabetes and obesity are two of the most pressing health challenges in North Carolina. More than 1 million North Carolinians live with diabetes, and over 2 million struggle with obesity. Diabetes is a leading cause of blindness, kidney failure, amputations, and cardiovascular disease, significantly shortening lives and contributing billions of dollars in health care costs. … Read more
UNC Health, Blue Cross NC Study Offers Clinical Evidence on How Food Delivery Models Can Reduce Food Insecurity and Improve Health OutcomesUNC researchers, including Seth Berkowitz, MD, MPH, and Darren DeWalt, MD, MPH, found that a monthly $40 food subsidy improved blood pressure among people facing food insecurity. The results were published in JAMA Internal Medicine. A first-of-its-kind clinical study shows that offering modest monthly grocery cards for produce leads to improvements in blood pressure compared … Read more
Evan Dellon Leads Phase 3 Trial on Cendakimab for Eosinophilic EsophagitisEvan Dellon, MD, MPH, a Professor in the Division of Gastroenterology and Hepatology at UNC and the Director of the Center for Esophageal Diseases and Swallowing, led a Phase 3 Trial on using Cendakimab for Eosinophilic Esophagitis (EoE). His study was published in NEJM Evidence with positive findings. Cendakimab is a high-affinity monoclonal antibody that … Read more
Sheikh, Lee & Niethammer Receive $4.4 Million 2-Year NIH Award to Advance Multi-Modal Machine Learning for Earlier Diagnosis of LupusFrom left to right: Saira Sheikh, MD, Yueh Lee, MD, PhD, Marc Niethammer, PhD A rheumatologist, neuroradiologist, and computer scientist have joined forces to blend medical expertise with AI/machine learning to reimagine the future of lupus diagnosis and care. Saira Sheikh, MD, the Linda Coley Sewell Distinguished Professor of Medicine at UNC and Chair of … Read more
John Buse Co-Publishes ‘STEP UP T2D’ on the Efficacy of Higher Semaglutide DosesJohn Buse, MD, the Verne S. Caviness Distinguished Professor of Medicine and Director of the UNC Diabetes Care Center, co-authored STEP UP T2D an international trial. STEP UP T2D found that a higher maintenance dose of semaglutide (7.2 mg once weekly) leads to significantly greater weight loss and improved blood sugar control in adults with … Read more
Center for Gastrointestinal Biology and Disease Receives 40th Consecutive Year of NIH FundingPictured are Dr. Robert Sandler and Julianne O’Daniel. Robert Sandler, MD, MPH, Professor of Medicine at the University of North Carolina at Chapel Hill and Director of the Center for Gastrointestinal Biology and Disease (CGIBD), has announced the renewal of the Center’s P30 Center grant from the National Institute of Diabetes and Digestive and Kidney … Read more
Gaurav Dave to serve as Research Director for NIH’s Building Interdisciplinary Research Careers in Women’s Health ProgramUNC-Chapel Hill has been announced as the recipient of a National Institutes of Health (NIH) Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) award. Created by the Office of Research on Women’s Health in partnership with NIH Institutes, Centers, and Offices, BIRCWH is a mentored career-development program designed to connect junior faculty to senior faculty … Read more
Shehzad Sheikh Identifies CADM1 as a Key Driver of Gut Inflammation in IBD PatientsShehzad Z. Sheikh, MD, PhD A groundbreaking study co-led by Shehzad Z. Sheikh, MD, PhD, professor of medicine in the UNC Division of Gastroenterology and Hepatology, and Matthew N. Poy, PhD, associate professor of medicine with Johns Hopkins University, reveals Cell Adhesion Molecule 1 (CADM1), a surface protein involved in cell-cell adhesion, is significantly elevated … Read more
PROMOTER Study Aims to Advance Translational Research in Esophageal DiseasesResearchers from the University of North Carolina and North Carolina State University aim to use a pig-based model to study esophageal diseases, a field where scientific understanding remains limited. Researchers use large animal models to help with therapy development, testing and translation. However, fully defined models of digestive diseases are still scarce. Within this field, … Read more
UNC Joins Phase 3 CATT1 Trial Investigating Cadisegliatin as Adjunctive Therapy for Type 1 DiabetesThe University of North Carolina will serve as a study site for the vTv Therapeutics Inc. CATT1 Phase 3 trial investigating cadisegliatin as an adjunctive treatment to insulin in adults with type 1 diabetes (T1D). Cadisegliatin is a potential first-in-class, oral, liver-selective glucokinase activator for T1D that has been granted Breakthrough Therapy designation by the … Read more
Ria Dancel Collaborates on Creation of Internal Medicine Residency POCUS RecommendationsRia Dancel, MD Ria Dancel, MD, FACP, SFHM, FAAP, Professor of Medicine and Pediatrics in the UNC Division of Hospital Medicine, collaborated with a group of academic teaching physicians to develop the first expert and evidence-based consensus on the core components of a point-of-care ultrasound (POCUS) curriculum for internal medicine residency training in the United … Read more
M. Bradley Drummond Found Promise in Using Digital Inhalers to Predict COPD Flare-upsDr.Brad Drummond M. Bradley Drummond, MD, MHS, a Professor of Medicine and the Director of the Obstructive Lung Diseases Clinical and Translational Research Center at UNC, published a pilot study in the Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation suggesting that digital inhaler technology may help predict worsening symptoms in COPD patients up … Read more